Health Tech startup Aisel Health raises €1.7M pre-seed to reinvent psychiatry

Aisel Health, the Danish HealthTech company building an Operating System (OS) purpose-built for psychiatry and mental health, today announced it has closed a €1.7 million pre-seed round. The round was led by Caesar Ventures, joined by Nordic Web Ventures, LifeX, and Angel Invest, alongside existing investors Rockstart and EIFO.

Psychiatry is unique, and it has been overlooked. For decades, mental healthcare has been underfunded, stigmatised, and passed over by innovation, while demand for psychiatric care is growing faster than health systems can absorb it: patients routinely wait weeks, months, or longer to see a clinician.

“Psychiatry doesn't need more generic technology bolted onto an already overburdened workflow. It needs a product built around the realities of psychiatric care - where clinicians bring judgment, empathy, and years of trained intuition, and the technology brings the speed, structure, and ability to hold together every detail about every patient, in a way no human memory can.” - Augusta Klingsten Peytz, Co-Founder and CEO of Aisel Health

An innovation wave has swept through psychiatric clinics over the past two years, as AI notetaking tools have moved in, promising to ease the load on overworked clinicians. But faster notes create a different problem: as documentation gets cheaper and quicker to produce, the information inside it gets harder to find. Patient records grow into an ever-longer trail scattered across systems and years - and the burden shifts from writing notes to searching them.

Aisel's latest research, "The Documentation Minute", found that psychiatrists spend far longer on evidence-gathering than on writing the note itself - pulling together a patient's history from referrals, prior notes, and multiple systems before they can even begin to assess and treat.

The result shows up everywhere: doctors usually have most of what they need already sitting somewhere in the system - they just can't find it fast enough. So instead of spending hours retracing a case, they ask the patient to repeat their history again.

“AI scribes work - they write notes faster, and that's great for immediate burnout. But that's not what's keeping waiting lists long. Make notes cheaper to produce, and you just make that information harder to find when a clinician needs it. We still have yet to overcome the human limitation of understanding everything that was ever written about every patient ever treated - that's the problem we built Aisel to solve: giving clinicians exactly what they need, when and how they need it.” - Christian Houen, Co-Founder and CPO of Aisel Health

Aisel's platform reduces documentation burden and surfaces the clinical history and context a psychiatrist needs, exactly when and how they need it. It turns interview recordings, existing documents and even the patient's own accounts into structured, contextual insights relevant to whatever moment the clinician is in. Before, during and after the consultation, Aisel offers direct insight into everything that was documented about the patient.

“Few problems in healthcare are as large or as overlooked as psychiatry's, and few founders are as passionate about solving it the way Augusta and Christian are. We're proud to lead this round, and look forward to supporting them to deliver the next generation of technology for psychiatry." - Carolin Gabor, Managing Partner and GP at Caesar Ventures

Aisel will use the funding to grow its clinical and engineering team and fund its UK market entry, converting an active commercial pipeline of private psychiatry, ahead of a planned seed round. The goal: give clinicians everything that matters about a patient, exactly when they need it - something no human memory, however well-trained, can do alone - and in doing so, help shorten the waiting lists that have defined psychiatric care for too long.

“We look for European quality and diligence and American ambitions - and we're thrilled to back Aisel as they prove both to change one of the biggest challenges of their generation.” - Amol Sarva, Managing Partner at LifeX Ventures

‍